Skip to main content
OpenTrials

Clinical trial condition

Thrombocytosis

Explore clinical trials studying Thrombocytosis. Study availability and eligibility vary by location and protocol.

177 public trials 30 recruiting studies
Refine in advanced search Browse all conditions

Thrombocytosis trial results

Completed

Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

NCT01259856

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • The Palo Alto Clinic Palo Alto, California, United States
  • Stanford University School of Medicine Stanford, California, United States
View all 25 locations
View Trial Details
Completed

Study of LY573636-sodium in Essential Thrombocythemia and Acute Myeloid Leukemia

NCT00718159

Conditions
Acute Myeloid Leukemia, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Los Angeles, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aurora, Colorado, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Baltimore, Maryland, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Las Vegas, Nevada, United States
View Trial Details
Completed

Correlative Biomarker Study in Patients With Myeloproliferative Disorders

NCT00665067

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +16 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • The Palo Alto Clinic Palo Alto, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Emory Hospital Atlanta, Georgia, United States
View all 22 locations
View Trial Details
Completed

A Study in Myeloproliferative Disorders

NCT01134120

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +12 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Houston, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Salt Lake City, Utah, United States
View Trial Details
Completed

Natural History Study of Fungal Infections of the Blood in Patients With Cancer or in Patients Who Have Undergone a Stem Cell Transplant

NCT00445952

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +116 more
Locations
  • Institut Jules Bordet Brussels, Belgium
  • CHU de Grenoble - Hopital de la Tronche Grenoble, France
  • German Hodgkin's Lymphoma Study Group Cologne, Germany
  • Ospedale San Martino Genoa, Italy
View Trial Details
Completed

Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

NCT00445744

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +39 more
Locations
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details

Related conditions